Pooja Mehta
About Pooja Mehta
Pooja Mehta serves as the Associate Director of Cell Culture and Upstream Development at Roivant Sciences in Raleigh, North Carolina, a position she has held since 2018. She holds a Bachelor of Science from the State University of New York College at Buffalo and a Master of Science from Johns Hopkins University.
Work at Roivant Sciences
Pooja Mehta has served as the Associate Director of Cell Culture and Upstream Development at Roivant Sciences since 2018. In this role, she is responsible for overseeing the development of cell culture processes and upstream production strategies. Her work is based in Raleigh, North Carolina, where she has contributed to the company's initiatives in biopharmaceutical development for six years.
Education and Expertise
Pooja Mehta earned a Bachelor of Science degree from the State University of New York College at Buffalo, completing her studies from 2004 to 2008. She further advanced her education by obtaining a Master of Science degree from Johns Hopkins University, where she studied from 2011 to 2014. Her educational background provides her with a solid foundation in the biological sciences and engineering principles relevant to her current role.
Professional Background
Pooja Mehta has a diverse professional background in the biotechnology and pharmaceutical industries. She began her career as an intern in product development at Trinity Biotech in 2007. Afterward, she worked at Talecris Biotherapeutics, Inc. as both a Process Development Scientist and a Product Development Scientist from 2009 to 2011. She then joined Bristol-Myers Squibb as an Associate Research Scientist for one year before moving to Novartis, where she held positions as Development Engineer II and Scientist I from 2011 to 2016.
Career Progression
Pooja Mehta's career has shown a clear trajectory of growth and increasing responsibility within the biotechnology sector. After her initial role at Trinity Biotech, she transitioned to Talecris Biotherapeutics, where she gained experience in both process and product development. Her subsequent roles at Bristol-Myers Squibb and Novartis further enhanced her expertise in research and development, culminating in her current position at Roivant Sciences, where she leads significant projects in cell culture and upstream development.